Industry News (Clinical Trials)

Results of Stem Cell Gene Therapy Trial Presented

Published in Gene Therapy Weekly, December 18th, 1995

Somatix Therapy Corp., Alameda, California, and Baxter Healthcare Corp. announced that their collaborator, Harry Malech, M.D. of the U.S. National Institute of Allergy and Infectious Disease (NIAID), a part of the U.S. National Institutes of Health (NIH), presented preliminary results of a gene therapy trial at the American Society of Hematology conference, held in Seattle, Washington.

Malech has treated the first patients in a novel Phase I clinical trial of progenitor cell gene therapy for the rare hereditary disorder, chronic granulomatous disease (CGD). In the five patient trial, three patients are far enough into treatment for analysis and preliminary evaluation. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-12-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry